<div id="readability-page-1">11:12 AM EST, 12/22/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts started the week higher late Monday morning, rising 0.51% to 1,670.42 on the S&amp;P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and biotech firm Evaxion ( EVAX ) , which climbed 8.7% and 4% respectively. They were followed by internet browser company Opera (OPRA) and pharmaceutical company Ascendis Pharma ( ASND ) , which advanced 3.7% and 2.6% respectively.The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and medical device maker EDAP TMS ( EDAP ) , which fell 10.6% and 4.3% respectively. They were followed by brewing company Anheuser-Busch InBev ( BUD ) and pharmaceutical company Novo Nordisk ( NVO ) , which were down 1.5% and 0.3% respectively.From the UK and Ireland, the gainers were led by biopharmaceutical company Mereo BioPharma Group ( MREO ) and biotech firm Autolus Therapeutics ( AUTL ) , which rose 13.5% and 8.9% respectively. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and mining company BHP Group ( BHP ) , which were up 5.2% and 2.8% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and alcoholic beverage company Diageo ( DEO ) , which dropped 6.9% and 2.4% respectively. They were followed by biopharmaceutical company NuCana ( NCNA ) and biotech firm Trinity Biotech ( TRIB ) , which lost 2.3% and 0.5% respectively. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

AUTL

MREO

European equities traded in the US as American depositary receipts rose 0.51% on the S&P Europe Select ADR Index. Notable gainers included Cellectis and Evaxion, while DBV Technologies and EDAP TMS led decliners. From the UK and Ireland, Mereo BioPharma Group and Autolus Therapeutics saw significant gains, whereas Biodexa Pharmaceuticals and Diageo experienced declines.

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading